Siemens Healthineers Integrates Hemostasis Product Offerings in USA and Europe

Siemens Healthineers and Sysmex Corporation have begun independent sales of their combined broad range of hemostasis testing systems to laboratories in the United States and Europe under each company’s own brand, providing healthcare providers with streamlined access to leading hemostasis testing solutions that support multiple patient conditions and disease states.

Newly added to the Siemens Healthineers portfolio are the CN-3000/6000,2 CS-2500, CS-5100 and CA-600 series of Siemens Healthineers branded systems, which are designed to accelerate testing and streamline workflows, whether stand-alone or connected to laboratory automation. These haemostasis testing systems complement Siemens Healthineers’ broader in vitro diagnostics portfolio, which includes chemistry, immunoassay, urinalysis, haematology, automation and IT solutions.

Siemens Healthineers and Sysmex have built a solid partnership over 25 years and together have become one of the leading solution providers in the global homeostasis segment. With the aim of providing customers worldwide with a broader and more effective range of homeostasis laboratory solutions, in February 2023 the two companies collaborated to market their combined homeostasis portfolio globally and individually under their respective company names, in combination with their own wider portfolios of products and services. Through our collaboration agreement with Sysmex, both companies now offer a proven portfolio of homeostasis testing instruments and assays that complement unique offerings that will greatly benefit laboratories worldwide,” said Robert Stowers, executive vice president and head of the Specialty Lab Solutions business for Diagnostics at Siemens Healthineers.

To view the source version, please click HERE.

en_GBEnglish (UK)